Google Übersetzer
Context Therapeutics Inc.
About
2.60USD+0.20 +8.33%
Closed • Updated at 12:47 GMT+00:00Market Cap$238.89M
Volume1.92M
Beta-0.55
RSI59.07
Context Therapeutics Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 18 2026
Context Therapeutics Enters into License Agreement Amendment with BioAtla for CT-202
May 6 2026
Context Therapeutics Reports First Quarter 2026 Operating and Financial Results
Apr 2 2026
Context Therapeutics Announces CTIM-76 Receives FDA Fast Track Designation for the Treatment of Platinum-Resistant Ovarian Cancer
Mar 23 2026
Context Therapeutics Reports Full Year 2025 Operating and Financial Results
Mar 19 2026
Context Therapeutics Announces Poster Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2026
Recent Videos
Cómo comprar acciones de Context Therapeutics Inc (CNTX)
Mar 19, 2026
Biotech Breakout or Bust? | CNTX stock analysis | Context Therapeutics stock prediction?
Feb 11, 2026
Up 93% This Year! Is Context Therapeutics (CNTX) the Next Big Runner? CNTX STOCK PODCAST TODAY PRICE
Jan 31, 2026
Context Therapeutics - Precision Oncology - $CNTX
Dec 25, 2025
Community Chat
Ask AI
Try asking